Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-31

Clinical Trial Update: Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pimavanserin for insomnia in veterans with PTSD has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimavanserin (pimavanserin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Post-traumatic Stress Disorder, Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2022-08-31